Healthcare Services

BNP and NT-proBNP market forecast with key trends and opportunities

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The BNP And NTproBNP Market Expected To Scale Between 2026 And 2030?

The market size for bnp and ntprobnp has experienced rapid growth in recent years. It is anticipated to increase from $2.26 billion in 2025 to $2.54 billion in 2026, with a compound annual growth rate (CAGR) of 12.2%. This historical expansion can be attributed to factors such as the rising prevalence of cardiovascular diseases, increased clinical adoption of bnp testing, the expansion of hospital diagnostic infrastructure, growing awareness for early heart failure detection, and the availability of laboratory immunoassay technologies.

The bnp and ntprobnp market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. Several factors are expected to fuel this growth during the forecast period, including a heightened demand for swift cardiac diagnostics, wider adoption of point-of-care testing, an expanding elderly demographic, the increasing incorporation of AI-assisted diagnostic analysis, and a greater emphasis on preventive cardiology care. Key trends identified for the forecast period encompass a growing uptake of high-sensitivity cardiac biomarker assays, increased utilization of point-of-care bnp testing devices, a broader integration of automated laboratory diagnostics, the expansion of early heart failure screening initiatives, and an intensified focus on diagnostic testing with quick turnaround times.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Which Primary Drivers Are Impacting The BNP And NTproBNP Market Growth?

The expansion of the BNP and NT-proBNP market is anticipated due to the increasing geriatric population. This demographic comprises older adults, generally identified as those aged 65 and above. In this elderly demographic, BNP and NT-proBNP act as crucial biomarkers, assisting in diagnosing and managing heart failure by offering significant information on heart function and facilitating suitable treatment approaches for older individuals. For example, the World Health Organization, a US-based specialized health agency, projected in October 2025 that worldwide, 1 in 6 individuals will be 60 or older by 2030, with this figure expected to climb to 2.1 billion elderly people by 2050. Consequently, the expanding geriatric population is fostering the market growth for BNP and NT-proBNP.

How Is The BNP And NTproBNP Market Organized By Segment Classification?

The bnp and ntprobnp market covered in this report is segmented –

1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications

Subsegments:

1) By BNP (Brain Natriuretic Peptide): BNP Testing Kits, Point-Of-Care BNP Testing Devices, Laboratory BNP Assays

2) By NT-ProBNP (N-Terminal Pro–B-Type Natriuretic Peptide): NT-ProBNP Testing Kits, Point-Of-Care NT-proBNP Testing Devices, Laboratory NT-ProBNP Assays

Which Trends Are Shaping Growth In The BNP And NTproBNP Market?

Leading companies within the BNP and NTproBNP market are intensifying their efforts to launch rapid screening bioassays, aiming to secure a competitive advantage. These rapid screening bioassays are biological tests designed to efficiently evaluate a substance’s presence, concentration, or activity by observing its impact on living cells or organisms, thus allowing for swift and dependable identification or classification of particular characteristics or states. As an illustration, in October 2023, Mindray Medical International Limited, a medical device firm headquartered in China, introduced two novel assays intended to assist in the diagnosis and management of cardiovascular diseases (CVDs). Specifically, these assays are named high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). The integration of these new assays into Mindray’s extensive collection of cardiac biomarkers has strengthened its capability to perform screening, risk stratification, rapid diagnosis, and therapy monitoring for CVDs. Mindray partnered with HyTest, a prominent innovator in cardiac biomarkers, to incorporate HyTest’s research and antibodies into its immunoassay platforms.

Who Are The Industry Participants Involved In The BNP And NTproBNP Market?

Major companies operating in the bnp and ntprobnp market are Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.

Get The Full BNP And NTproBNP Market Report:

https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Which Region Is The Leading Market For The BNP And NTproBNP Market?

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2025.North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized BNP And NTproBNP Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

Browse Through More Reports Similar to the Global BNP And NTproBNP Market 2026, By The Business Research Company

Consumer And Smb Nas Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-and-smb-nas-global-market-report

B2B2C Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/b2b2c-insurance-global-market-report

B2B Telecommunication Market Report 2026

https://www.thebusinessresearchcompany.com/report/b2b-telecommunication-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795